About the cover: Compounds that target the influenza protein neuraminidase (NA) can lose activity as a result of point mutations in the NA binding site. The graphic shows NA in complex with the drug zanamivir and MD simulation results for the change in H-bonding caused by a deleterious R292K mutation for four inhibitors. Background image showing an emergency hospital during the 1918 influenza epidemic courtesy of the Nationa
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.